PRNewswire

A comprehensive new litmus test for alignment to the science of reading

SYRACUSE, N.Y., May 3, 2024 /PRNewswire/ -- The Reading League (TRL), a nonprofit organization leading the advancement of evidence-aligned reading instruction, has launched its ground-breaking Curriculum Navigation Reports, which are unbiased reviews of how reading curricula measure up to the scientific evidence base.  

... (continue reading...)

• Newly formed Restore Our Campuses Coalition (ROCC) representing broad cross-section of American schools spotlights inaction by university leadership
• Calls for removal of federal funding of schools in violation of Title VI
• Seeks termination of faculty and expulsion of students who are in breach of university codes of conduct
• Requests Congress work with the Administration to deport non-U.S. students who engage in antisemitic activity

WASHINGTON, May 3, 2024 /PRNewswire/... (continue reading...)

Annual Family Wealth Report Awards Recognize the Most Innovative and Exceptional Firms, Teams and Individuals Serving the Family Office, Family Wealth and Trusted Advisor Communities in North America

CHICAGO, May 3, 2024 /PRNewswire/ -- HUB Private Client, a division of HUB International (HUB) focusing on insurance and risk management needs of affluent individuals, has won the 2024 Family Wealth Report (FWR) Awards in the category of Best Insurance Brokerage... (continue reading...)

DURHAM, N.C., May 3, 2024 /PRNewswire/ -- Corevist, the B2B ecommerce platform that powers customer-central digital channels, today announced the winners of the inaugural Golden Bull Awards, which recognizes outstanding achievements in B2B digital commerce, spotlighting clients who have excelled in utilizing the Corevist platform to enhance their online sales channel.

... (continue reading...)

ST. JOSEPH, Mo., May 3, 2024 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, celebrated a new and innovative laboratory space at its St. Joseph, Mo. location by hosting a ribbon cutting. This state-of-the-art facility is set to revolutionize the development of future products, including biotherapeutics.

The new laboratory is a testament to Boehringer's commitment to innovation and excellence. This unique late-stage R&D laboratory, the only one... (continue reading...)